Optimization of fermentation conditions and medium components for chrysomycin a production by Streptomyces sp. 891-B6

Zhe Hu,Qiangang Weng,Zhehui Cai,Huawei Zhang
DOI: https://doi.org/10.1186/s12866-024-03258-9
IF: 4.465
2024-04-08
BMC Microbiology
Abstract:Chrysomycin A (CA) is a promising antibiotic for treatment of Gram-positive bacterial infections and cancers. In order to enhance CA yield, optimization of fermentation conditions and medium components was carried out on strain Streptomyces sp. 891-B6, an UV-induced mutant with improved CA titer compared with its wide-type marine strain 891.
microbiology
What problem does this paper attempt to address?
The paper mainly addresses the following issues: 1. **Demand for increased yield**: The paper focuses on increasing the yield of the natural product Chrysomycin A (CA) produced by the marine-derived Streptomyces sp. 891. Researchers obtained a mutant strain 891-B6 through UV mutagenesis, which can produce a higher proportion of the target compound CA. 2. **Optimization of fermentation conditions and medium components**: To further increase the yield of CA, the research team optimized the fermentation conditions and medium components through single-factor experiments and response surface methodology (based on Box-Behnken design). These conditions include seed age, inoculum size, liquid volume, initial pH value, and the concentrations of glucose, corn starch, and soybean meal in the medium. 3. **Foundation for large-scale production**: Through the above optimizations, researchers identified a set of optimal fermentation conditions under which the yield of CA significantly increased to 1601.9 ± 56.7 mg/L, approximately 60% higher than the original yield. This provides an important foundation for subsequent large-scale production. In summary, this paper aims to increase the yield of Chrysomycin A by optimizing fermentation conditions and medium components, with the goal of accelerating the development of new anti-drug resistance drugs.